Moderna (MRNA) Non Operating Income: 2018-2025
Historic Non Operating Income for Moderna (MRNA) over the last 7 years, with Jun 2025 value amounting to $8.0 million.
- Moderna's Non Operating Income rose 129.63% to $8.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$37.0 million, marking a year-over-year increase of 72.79%. This contributed to the annual value of -$87.0 million for FY2024, which is 29.84% up from last year.
- Per Moderna's latest filing, its Non Operating Income stood at $8.0 million for Q2 2025, which was up 300.00% from -$4.0 million recorded in Q1 2025.
- Over the past 5 years, Moderna's Non Operating Income peaked at $14.0 million during Q2 2023, and registered a low of -$51.0 million during Q3 2023.
- Moreover, its 3-year median value for Non Operating Income was -$23.0 million (2024), whereas its average is -$20.7 million.
- Its Non Operating Income has fluctuated over the past 5 years, first slumped by 900.00% in 2021, then surged by 207.69% in 2023.
- Quarterly analysis of 5 years shows Moderna's Non Operating Income stood at -$7.0 million in 2021, then crashed by 71.43% to -$12.0 million in 2022, then plummeted by 225.00% to -$39.0 million in 2023, then increased by 25.64% to -$29.0 million in 2024, then soared by 129.63% to $8.0 million in 2025.
- Its last three reported values are $8.0 million in Q2 2025, -$4.0 million for Q1 2025, and -$29.0 million during Q4 2024.